The US OTC drug market is anticipated to grow at a CAGR of 5.8% during the forecast period. The pharma players are increasingly shifting towards the OTC landscape owing to the growing preference of consumers and are bringing new drugs at an affordable price in the market. For the pharma companies in the US, OTC […]